Badri Rengarajan, n/a

North America Region Medical Director, Oncology
Jazz Pharmaceuticals plc, Dublin, Ireland, Ireland

Poster(s):

• (328) Healthcare resource utilization (HCRU) and costs during second-line (2L) treatment for small-cell lung cancer (SCLC)
  Wednesday, October 29, 2025